COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
GH Stock | USD 30.44 0.93 2.96% |
Under 81 percent of Guardant Health's traders are selling. The analysis of overall sentiment of trading Guardant Health stock suggests that a large number of investors are terrified at this time. Guardant Health's investing sentiment shows overall attitude of investors towards Guardant Health.
Guardant |
COTA Inc., a leader in real-world data and analytics for oncology, announces a new partnership with leading precision oncology company Guardant
Read at businesswire.com
Guardant Health Current Investor Sentiment
Panic Vs Confidence
19
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Guardant Health's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Guardant Health.
News SentimentBearish | Hype SentimentBearish | Insider SentimentDisposing |
Guardant Health Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Guardant Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Guardant Health Fundamental Analysis
We analyze Guardant Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardant Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardant Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
Guardant Health is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Guardant Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Guardant Health stock to make a market-neutral strategy. Peer analysis of Guardant Health could also be used in its relative valuation, which is a method of valuing Guardant Health by comparing valuation metrics with similar companies.
Peers
Guardant Health Related Equities
PSNL | Personalis | 2.79 | ||||
NTRA | Natera | 0.39 | ||||
CDNA | Caredx | 0.09 | ||||
DHR | Danaher | 0.04 | ||||
ILMN | Illumina | 0.18 | ||||
A | Agilent Technologies | 0.21 | ||||
CRL | Charles River | 0.26 | ||||
TMO | Thermo Fisher | 0.34 | ||||
MYGN | Myriad Genetics | 0.59 | ||||
TWST | Twist Bioscience | 2.15 | ||||
CSTL | Castle Biosciences | 2.24 |
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Stocks Directory Find actively traded stocks across global markets |